A regulatory veterinarian, a laboratory director, and an equine researcher shared the stage — not as a punchline, but as an ...

Karim, Executive Vice President of Integrated Marketing and Communications, EEMEA at Mastercard, makes the case for a passion ...

Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced participation in the following scientific a ...

Confirmed, pooled, blinded COVID-19 events in the ongoing Phase 3 DECLARATION study of VYD2311 accumulated to date (~ 50% of study progress) can ...

In 2025, 56.9% of all the pitches Senzatela threw were four seam fastballs. He did that despite that pitch having the second ...

Steven J. Vancore is the president of Clearview Research. He has nearly 40 years of experience conducting polls and focus ...

Gregory McVay, group vice president and chief customer officer at Danaher Life Sciences, discusses how automation and AI can ...

Many claim to have ‘saltwater in their veins,’ but all you have to do is walk into the corner office of John McDonald, the ...

How a central vacuum system from Busch Vacuum Solutions optimizes the CNC process at Trappenfabriek Vermeulen BV.

A cheerleader for the very real-world magic of psychedelics, Michael Pollan talks about his new journey to the heart of ...

Seer Inc. SEER on Thursday said its Proteograph Product Suite will serve as the mass spectrometry-based workflow to profile ...

As the war in the Middle East rages on, shareholders of legacy defense major Lockheed Martin (LMT) should be a happy lot. The stock is up almost 30% on a year-to-date (YTD) basis and looks set for ...